Address:
Hubei,China
Main Products:
pharmaceutical intermediates
Dextran 70
Quick Details
Product Name | Dextran 70 | Other Names | dextran11;dextran2; dextran5; DextrangradeA,B,C; dextrans;Dextraven; Ex-pandex;Gentran3 |
CAS No | 9004-54-0 | MF | [C6H10O5]n |
Assay | 99% | MW | Variable |
Appearance | White powder | Function | Anti-anemia drug. For iron deficiency anemia |
Description
--------------------------------------------
Dextran is a complex branched glucan (polysaccharide made of many glucosemolecules) composed of chains of varying lengths (from 3 to 2000kilodaltons). It is used
medicinally as an antithrombotic (antiplatelet), to reduce blood viscosity, and as a volume
expander in hypovolaemia.
The straight chain consists of α-1,6 glycosidic linkages between glucose molecules, while branches begin from α-1,3 linkages. Dextran is
synthesized from sucrose by certain lactic acid bacteria, the best-known being Leuconostoc mesenteroides and Streptococcus mutans. Dental plaque is rich in dextrans.
Dextran was first discovered by Louis Pasteur as a microbial product in wine.
Applications
--------------------------------------------------
Adjust dosage and rate of infusion based on individual patient requirements, fluid loss amount, and
resultant hemoconcentration. (See Rate of Administration under Dosage and Administration.)
Children: Limited use suggests basing dosage on patient body weight or surface area; maximum total
dosage 20 mL/kg(See Pediatric Patients under Cautions.)
Adjust dosage and rate of infusion based on individual patient requirements, fluid loss amount, and
resultant hemoconcentration. (See Rate of Administration under Dosage and Administration.)
Usual dose: 30 g (500 mL). Maximum total dosage (first 24 hours): 1.2 g/kg (20 mL/kg);thereafter,
maximum total dosage of 0.6 g/kg (10 mL/kg) daily.
Children: Maximum total dosage 20 mL/kg.
First 24 hours: Maximum total dosage 1.2 g/kg (20 mL/kg).Thereafter, maximum total dosage 0.6 g/kg
(10 mL/kg) daily.
★Known hypersensitivity to dextran or any ingredient in the formulation.
(See Sensitivity Reactions under Cautions.)
★Severe bleeding disorders.
★Severe congestive cardiac failure.
★Renal failure.
Medical Uses
---------------------------------------------
These agents are used commonly by microsurgeons to decrease vascular thrombosis. The antithrombotic effect of dextran is mediated through its binding of erythrocytes, platelets, and vascular endothelium, increasing theirelectronegativity and thus reducing erythrocyte aggregation and platelet adhesiveness. Dextrans also reduce factor VIII-Ag Von Willebrand factor, thereby decreasing platelet function. Clots formed after administration of
dextrans are more easily lysed due to an altered thrombus structure (more evenly distributed platelets
with coarserfibrin[citation needed]). By inhibiting α-2 antiplasmin, dextran serves as a plasminogen activator, so possessesthrombolytic features.
Outside from these features, larger dextrans, which do not pass out of the vessels, are potent osmotic
agents, thus have been used urgently to treat hypovolemia. The hemodilution caused by volume expansion with dextran use improves blood flow,
thus further improving patency of microanastomoses and reducing thrombosis. Still, no difference
has been detected in antithrombotic effectiveness in comparison of intra-arterial and intravenous administration of dextran.
Dextrans are available in multiple molecular weights ranging from 3,000 Da to 2,000,000 Da. The larger
dextrans (>60,000 Da) are excreted poorly from the kidney, so remain in the blood for as long as weeks
until they are metabolized. Consequently, they have prolonged antithrombotic and colloidal effects. In this family, dextran-40 (MW: 40,000 Da), has been the most popular member for
anticoagulation therapy. Close to 70% of dextran-40 is excreted in urine within the first 24 hours after intravenous infusion, while the remaining 30% are
retained for several more days.
· It is used in some eye drop
as a lubricant.and in certain intravenous fluids to solubilize other factors, such as iron
(in a solution known as Iron Dextran).
· Intravenous solutions with dextran function both as volume expanders and means of parenteral nutrition. Such a solution provides an osmotically neutral fluid that once in the body is
digested by cells into glucose and free water. It is occasionally used to replace lost blood in emergency situations, when replacement blood is not available, but must be used with caution
as it does not provide necessary electrolytes and can causehyponatremia or other electrolyte disturbances.
· It also increases blood sugar levels
· Dextran is used in the osmotic stress technique for applying osmotic pressure to biological molecules.
· It is also used in some size-exclusion chromatography matrices; an example is Sephadex.
· Dextran has also been used in bead form to aid in bioreactor applications.
· Dextran has been used in immobilization in biosensors.
· Dextran preferentially binds to early endosomes; fluorescent-labelled dextran can be used to visualize these endosomes under a fluorescent microscope.
· Dextran can be used as a stabilizing coating to protect metal nanoparticles from oxidation and
improve biocompatibility.
· Dextran coupled with a fluorescent molecule such as fluorescein isothiocyanat
can be used to create concentration gradients of diffusible molecules for imaging and allow
subsequent characterization of gradient slope.
· Dextran is used to make microcarriers for industrial cell culture
Side Effects
---------------------------------------------
Although relatively few side effects are associated with dextran use, these side effects can be very
serious. These include anaphylaxis, volume overload, pulmonary edema, cerebral edema, or platelet dysfunction.
An uncommon but significant complication of dextran osmotic effect is acute renal failure. The pathogenesis of this renal failure is the subject of many debates with direct
toxic effect on tubules and glomerulus versus intraluminal hyperviscosity being some of the proposed mechanisms. Patients with history
of diabetes mellitus, renal insufficiency, or vascular disorders are most at risk. Brooks and others recommend the
avoidance of dextran therapy in patients with chronic renal insufficiency.
Ask a doctor before use if you have narrow angle glaucoma
When using this product
· pupils may become enlarged temporarily
· overuse may cause more eye redness
· remove contact lenses before using
· do not use if this solution changes color or becomes cloudy
· do not touch tip of container to any surface to avoid contamination
· replace cap after each use
Stop use and ask a doctor if
· you feel eye pain
· changes in vision occur
· redness or irritation of the eye lasts
· condition worsens or lasts more than 72 hours
Why Choose Us?
-------------------------------------------
1. We are an experienced and professional chemical raw materials factory in China for
over 10 years, all products are supplied directly by our factory.
2. We have professional team in R&D , Quality Inspection, Sales, Package and transport.
We ensure that all the product are qualified with high quality ,reasonable prices and
safety delivery.
3. Delivery within 24 hours after payment. Feedback of Logistics information will be in
time to you.
4. Our products are available both in home and abroad .We would like to try our best
to meet your needs.